<http://webisa.webdatacommons.org/66655045>	<http://www.w3.org/ns/prov#value>	"$8.2 million of revenue from royalties paid by Covidien on net sales of Exalgo and from our research and development collaborations with Novartis, Amgen and other companies as well as from grants from NIAID and USAMRIID. For the year ended" .
<http://webisa.webdatacommons.org/prov/231142393>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/66655045> .
<http://webisa.webdatacommons.org/66655045>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/66655045>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<getfilings.com> .
<http://webisa.webdatacommons.org/prov/344977937>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/66655045> .